The SOPHiA DDM™ Dx Hereditary Cancer Solution is an in vitro diagnostic test intended for the identification of germline variations occurring in 27 most common genes involved in predispositions to breast and ovarian cancers as well as intestinal cancers in germline DNA samples isolated from peripheral blood. It is intended to be used as an aid to healthcare professionals and to provide molecular rationale to make a clinical decision related to germline mutations associated with breast and ovarian cancer, intestinal polyposis syndromes, and Lynch syndrome.
Cancer:
Breast Cancer, Gastrointestinal Cancer, Ovarian Cancer